Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study of DBV712 skin patch safety in children aged 1-3 years with peanut allergy
Not recruiting
Investigated Drugs:
Study of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
Not recruiting
Investigated Diseases:Investigated Drugs:
+5
Study of alpelisib in children and adults with PIK3CA-Related Overgrowth Spectrum (PROS)
Not recruiting
Investigated Drugs:
Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
Not recruiting
Investigated Diseases:
+1
Study of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
Not recruiting
Investigated Diseases:
+4
Study of bitopertin to improve sunlight tolerance in adults with erythropoietic protoporphyria or X-linked protoporphyria
Not recruiting
Investigated Diseases:
+3
Study of rMenB+OMV NZ meningococcal group B vaccine immune response and safety in previously vaccinated healthy participants aged 10 to 20 years
Not recruiting
Investigated Diseases:Investigated Drugs:- Outer Membrane Vesicles (Omv) From Neisseria Meningitidis Group B Strain Nz98/254 Measured As Amount Of Total Protein Containing The Pora P1.4 Adsorbed On Aluminium Hydroxide
- Recombinant Neisseria Meningitidis Group B Fhbp Fusion Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide
- Recombinant Neisseria Meningitidis Group B Nada Protein Produced In E. Coli Cells By Recombinant Dna Technology Adsorbed On Aluminium Hydroxide
